198 related articles for article (PubMed ID: 35238170)
21. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL
Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863
[TBL] [Abstract][Full Text] [Related]
22. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z
Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164
[TBL] [Abstract][Full Text] [Related]
24. XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway.
Jian J; Li S; Liu LZ; Zhen L; Yao L; Gan LH; Huang YQ; Fang N
Int J Mol Med; 2020 Jul; 46(1):201-210. PubMed ID: 32377720
[TBL] [Abstract][Full Text] [Related]
25. Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Li J; Chen Y; Zhan C; Zhu J; Weng S; Dong L; Liu T; Shen X
Dig Dis Sci; 2019 Jun; 64(6):1493-1502. PubMed ID: 30730015
[TBL] [Abstract][Full Text] [Related]
26. Dandelion root extract affects ESCC progression
Duan X; Pan L; Deng Y; Liu Y; Han X; Fu H; Li Y; Li M; Wang T
Food Funct; 2021 Oct; 12(19):9486-9502. PubMed ID: 34476429
[TBL] [Abstract][Full Text] [Related]
27. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
28. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
[TBL] [Abstract][Full Text] [Related]
29. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.
Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S
Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353
[TBL] [Abstract][Full Text] [Related]
30. PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.
Chang Z; Jia Y; Gao M; Song L; Zhang W; Zhao R; Yu D; Liu X; Li J; Qin Y
Biol Direct; 2024 Mar; 19(1):19. PubMed ID: 38429756
[TBL] [Abstract][Full Text] [Related]
31. AKAP12 inhibits esophageal squamous carcinoma cell proliferation, migration, and cell cycle via the PI3K/AKT signaling pathway.
Li X; Dong H; Zheng Y; Ding S; Li Y; Li H; Huang H; Zhong C; Xie T; Xu Y
Mol Cell Probes; 2023 Dec; 72():101939. PubMed ID: 37879503
[TBL] [Abstract][Full Text] [Related]
32. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
[TBL] [Abstract][Full Text] [Related]
33. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway.
Ma S; Liu T; Xu L; Wang Y; Zhou J; Huang T; Li P; Liu H; Zhang Y; Zhou X; Cui Y; Zang X; Wang Y; Guan F
J Cell Physiol; 2019 Dec; 234(12):22400-22410. PubMed ID: 31120582
[TBL] [Abstract][Full Text] [Related]
35. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma.
Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
[TBL] [Abstract][Full Text] [Related]
37. SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway.
Shi H; Luo J; Ye L; Duan C; Zhang M; Ran H; Li C; Wu Q; Shao Y
Cell Signal; 2024 Feb; 114():110997. PubMed ID: 38043670
[TBL] [Abstract][Full Text] [Related]
38. Sporoderm-Removed
Liu G; Zeng T
Integr Cancer Ther; 2021; 20():15347354211062157. PubMed ID: 34841952
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.
Du J
Anticancer Drugs; 2019 Jul; 30(6):596-603. PubMed ID: 30672777
[TBL] [Abstract][Full Text] [Related]
40. COL8A1 Regulates Esophageal Squamous Carcinoma Proliferation and Invasion Through PI3K/AKT Pathway.
Hu J; Li P; Dan Y; Chen Z; Lu Y; Chen X; Yan S
Ann Surg Oncol; 2024 May; 31(5):3502-3512. PubMed ID: 38429534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
